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The correct Table 2 is mentioned below:

###### 

Univariate and multivariate analyses of risk factors for acquisition of fluoroquinolone or aminoglycoside resistance in addition to imipenem resistance in *Pseudomonas aeruginosa*.

                                                                         Univariate analysis   Multivariate analysis                                 
  ---------------------------------------------------------------------- --------------------- ----------------------- --------- ------ ------------ ---------
  Resistance to FQs                                                                                                                                  
  Transplantation                                                        1.74                  0.80-3.78               0.161                         
  Use of corticosteroids (≥5 mg/day) or other immunosuppressive agents   1.81                  0.93-3.52               0.082                         
    Surgery                                                              0.65                  0.35-1.21               0.173                         
    Exposure to first-generation cephalosporins                          0.60                  0.30-1.19               0.143                         
    Exposure to second-generation cephalosporins                         0.28                  0.08-1.01                 0.051                       
  Exposure to FQs                                                        5.30                  2.52-11.14              \<0.001   5.73   2.67-12.30   \<0.001
  Exposure to AGs                                                        3.92                  1.30-11.87              0.016                         
  MBL production                                                         6.67                  1.78-24.91              0.005     7.90   2.01-31.04     0.003
  Resistance to AGs                                                                                                                                  
  Use of anticancer drugs                                                2.57                  0.64-10.40              0.184                         
  Use of urinary catheter                                                0.42                  0.13-1.38               0.152                         
    Exposure to antipseudomonal penicillins                              0.24                  0.05-1.14               0.073     0.16   0.03-0.89      0.036
  Exposure to AGs                                                        6.04                  1.59-23.00              0.008     9.00   1.92-42.19     0.005
  MBL production                                                         7.35                  1.89-28.65              0.004     8.49   1.87-38.52     0.006

OR, odds ratio; CI, confidence interval; FQs, fluoroquinolones; AGs, aminoglycosides; MBL, metallo-β-lactamase

The original table provided was:

###### 

Proportion of resistant and MBL-producing strains by presence of FQ or AG resistance in imipenem-resistant *Pseudomonas aeruginosa*.

                                          **Resistance to FQs**   **Resistance to AGs**                                    
  --------------------------- ----------- ----------------------- ----------------------- --------- ---------- ----------- -------
  Resistance to antibiotics                                                                                                
  Piperacillin^1)^            36 (21.3)   21 (31.8)               15 (14.6)               0.003     4 (33.3)   32 (20.4)   0.347
  Ceftazidime^1)^             53 (31.4)   33 (50.0)               20 (19.4)               \<0.001   8 (66.7)   45 (28.7)   0.022
  Cefepim                     38 (22.5)   28 (42.4)               10 (9.7)                \<0.001   7 (58.3)   31 (19.7)   0.006
  Aztreonam                   91 (53.8)   45 (68.2)               46 (44.7)               0.004     9 (75.0)   82 (52.2)   0.146
  Ciprofloxacin^1)^           49 (29.0)   \-                      \-                      \-        8 (66.7)   41 (26.1)   0.011
  Levofloxacin                60 (35.5)   \-                      \-                      \-        6 (50.0)   54 (34.4)   0.350
  Gentamicin^1)^              12 (7.1)    8 (12.1)                4 (3.9)                 0.042     \-         \-          \-
  Amikacin^1)^                4 (2.4)     3 (4.5)                 1 (1.0)                 0.274     \-         \-          \-
  MBL production              14 (8.3)    11 (16.7)               3 (2.9)                 0.003     4 (33.3)   10 (6.4)    0.010

Values are expressed as the number (%). FQs, fluoroquinolones; AGs, aminoglycosides; MBL, metallo-β-lactamase ^1)^Minimum inhibitory concentrations (MICs) for piperacillin, ceftazidime, ciprofloxacin, gentamicin and amikacin were not measured in eleven, one, one, one, and thirteen strains, respectively.
